Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Acta Neurochir (Wien). 2012 Oct;154(10):1773-9. doi: 10.1007/s00701-012-1433-y. Epub 2012 Jul 8.
Axonal regeneration in peripheral nerves after injury is a complicated process. Numerous cytokines, growth factors, channels, kinases, and receptors are involved, and matrix metalloproteinase-9 (MMP-9) has been implicated in the pathogenesis subsequent to nerve injury. In this study, the effect of KMUP-1, an activator of large-conductance Ca(2+)-activated potassium channel, on functional recovery, myelinated axon growth, and immunoreactivity of MMP-9 was evaluated in rats subjected to sciatic nerve crush injury.
A total of 144 male Sprague-Dawley rats were divided into the following six groups (n = 24/group): group 1, sham-operated; group 2, sciatic nerve injury without treatment; group 3, injured and vehicle-treated; group 4, injured and treated with 1 mM KMUP-1 by topical application; group 5, injured and treated with 10 mM KMUP-1; group 6, injured and treated with 50 mM KMUP-1. Functional recovery was evaluated using walking track analysis at 1, 2, 3, and 4 weeks (n = 6/group at each time point) after injury. In addition, the number of myelinated axons and MMP-9 in the nerve was also examined.
Animals subjected to sciatic nerve crush injury had decreased motor function, a reduced number of myelinated axons, and increased MMP-9 in the nerve. Treatment with KMUP-1 concentration-dependently improved functional recovery, increased the number of myelinated axons, and decreased MMP-9.
These results suggest that KMUP-1 may be a novel agent for assisting peripheral nerve recovery after injury. The beneficial effect is probably due to known ability of the compound in activating the nitric oxide/cGMP/protein kinase G pathway.
外周神经损伤后的轴突再生是一个复杂的过程。许多细胞因子、生长因子、通道、激酶和受体都参与其中,基质金属蛋白酶-9(MMP-9)已被认为与神经损伤后的发病机制有关。在这项研究中,研究了大电导钙激活钾通道激活剂 KMUP-1 对坐骨神经挤压伤大鼠功能恢复、有髓轴突生长和 MMP-9 免疫反应的影响。
共 144 只雄性 Sprague-Dawley 大鼠分为以下六组(每组 n = 24):第 1 组,假手术;第 2 组,坐骨神经损伤未治疗;第 3 组,损伤且用载体处理;第 4 组,损伤且用 1 mM KMUP-1 局部处理;第 5 组,损伤且用 10 mM KMUP-1 处理;第 6 组,损伤且用 50 mM KMUP-1 处理。损伤后 1、2、3 和 4 周(每组 n = 6)使用行走轨迹分析评估功能恢复。此外,还检查了神经中的有髓轴突数量和 MMP-9。
坐骨神经挤压伤动物运动功能下降,有髓轴突数量减少,神经中 MMP-9 增加。KMUP-1 浓度依赖性地改善功能恢复,增加有髓轴突数量,减少 MMP-9。
这些结果表明,KMUP-1 可能是一种新的辅助损伤后周围神经恢复的药物。这种有益作用可能是由于该化合物激活一氧化氮/cGMP/蛋白激酶 G 途径的已知能力。